/Resmed%20Inc_%20HQ%20photo-by%20JHVEPhoto%20via%20iStock.jpg)
ResMed has outpaced the broader Nasdaq Composite index over the past year, and Wall Street analysts are moderately bullish about the stock’s prospects.
/West%20Pharmaceutical%20Services%2C%20Inc_%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
West Pharmaceutical Services has underperformed other medical devices stocks over the past year, yet analysts remain bullish on the stock’s prospects.
Brett Sandercock, the Chief Financial Officer of $RMD ($RMD), sold 1,000 shares of the company on 12-09-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1%...
The Cooper Companies, Inc. COO delivered fourth-quarter fiscal 2024 adjusted earnings per share (EPS) of $1.04, which improved 19.5% year over year. The figure surpassed the Zacks Consensus Estimate by...
PETER C FARRELL, a director at $RMD ($RMD), sold 2,000 shares of the company on 12-04-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.4% of their shares....
Michael J Rider, the Global General Counsel of $RMD ($RMD), sold 74 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.8% of...
Justin Leong, the Chief Product Officer of $RMD ($RMD), sold 6,160 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 22.1% of...
Although ResMed has outperformed relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.
Alcon, Inc. ALC delivered core earnings per share (EPS) of 81 cents for the third quarter of 2024, up 22.7% from the year-ago quarter’s figure (up 25% at the constant exchange rate or CER). The figure...
/CNW/ -- Recently the World Economic Forum released a report that highlights AI's potential to relieve pressure on healthcare systems worldwide, with Mayo...